Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Gene variation affects prostate issues and hair loss.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

CEC levels may be a useful marker for predicting prostate cancer progression.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

The link between anabolic agents and colorectal cancer risk is unclear.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The ketogenic diet might improve certain skin conditions, but more research is needed to confirm its effectiveness.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.